Promentis Pharmaceuticals

0 followers


Promentis Pharmaceuticals focuses on developing antipsychotic drugs to treat schizophrenia.

Employees

11-50

Links


Org chart

Chad E. Beyer
SVP of Research and Development
Stacy Holland
VP of Finance

Board & advisors

Tim Keane
Director
David A. Baker
Scientific Advisor
Darin D. Dougherty
Scientific Advisor
Jon E. Grant
Scientific Advisor
Daniel C. Javitt
Scientific Advisor
Peter W. Kalivas
Scientific Advisor